MA26756A1 - Derives de thiazole - Google Patents

Derives de thiazole

Info

Publication number
MA26756A1
MA26756A1 MA26171A MA26171A MA26756A1 MA 26756 A1 MA26756 A1 MA 26756A1 MA 26171 A MA26171 A MA 26171A MA 26171 A MA26171 A MA 26171A MA 26756 A1 MA26756 A1 MA 26756A1
Authority
MA
Morocco
Prior art keywords
thiazole derivatives
thiazole
derivatives
Prior art date
Application number
MA26171A
Other languages
English (en)
Inventor
Kurt Hilpert
Leo Alig
Thomas Weller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26756A1 publication Critical patent/MA26756A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA26171A 1998-10-22 2001-04-20 Derives de thiazole MA26756A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98119985 1998-10-22

Publications (1)

Publication Number Publication Date
MA26756A1 true MA26756A1 (fr) 2004-12-20

Family

ID=8232838

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26171A MA26756A1 (fr) 1998-10-22 2001-04-20 Derives de thiazole

Country Status (31)

Country Link
US (1) US6297266B1 (fr)
EP (1) EP1123283B1 (fr)
JP (1) JP3530137B2 (fr)
KR (1) KR100469219B1 (fr)
CN (1) CN1211375C (fr)
AR (1) AR023058A1 (fr)
AT (1) ATE266012T1 (fr)
AU (1) AU760219B2 (fr)
BR (1) BR9914666A (fr)
CA (1) CA2347741C (fr)
CO (1) CO5150186A1 (fr)
CZ (1) CZ20011395A3 (fr)
DE (1) DE69917058T2 (fr)
DK (1) DK1123283T3 (fr)
ES (1) ES2221482T3 (fr)
HK (1) HK1047281A1 (fr)
HR (1) HRP20010275A2 (fr)
HU (1) HUP0104202A3 (fr)
ID (1) ID28356A (fr)
IL (1) IL142090A0 (fr)
MA (1) MA26756A1 (fr)
NO (1) NO20011908D0 (fr)
NZ (1) NZ510676A (fr)
PE (1) PE20001116A1 (fr)
PL (1) PL347427A1 (fr)
PT (1) PT1123283E (fr)
RU (1) RU2214404C2 (fr)
TR (1) TR200101115T2 (fr)
WO (1) WO2000024724A1 (fr)
YU (1) YU29201A (fr)
ZA (1) ZA200102653B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
WO2000062778A1 (fr) * 1999-04-15 2000-10-26 Bristol-Myers Squibb Co. Inhibiteurs cycliques de proteine tyrosine kinase
JP2004501863A (ja) * 2000-01-19 2004-01-22 アルテオン　インコーポレーテッド チアゾール、イミダゾールおよびオキサゾール化合物、ならびにタンパク質老化関連疾患の治療
ATE357444T1 (de) 2000-08-17 2007-04-15 Lumera Corp Design und synthese von nlo-materialien für electro-optische anwendungen, die von thiophen abgeleitet sind
AU2002231139B2 (en) 2000-12-21 2007-03-22 Bristol-Myers Squibb Company Thiazolyl inhibitors of tec family tyrosine kinases
CN101031567B (zh) * 2004-09-20 2011-12-21 4Sc股份有限公司 新型杂环NF-κB抑制剂
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
WO2010012793A1 (fr) * 2008-08-01 2010-02-04 Bayer Cropscience Sa Dérivés d'aminothiazole fongicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
CA2037153A1 (fr) * 1990-03-09 1991-09-10 Leo Alig Derives de l'acide acetique
US5273982A (en) 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
JPH0987237A (ja) * 1995-09-21 1997-03-31 Kyowa Hakko Kogyo Co Ltd 芳香族誘導体
SI0928790T1 (en) * 1998-01-02 2003-06-30 F. Hoffmann-La Roche Ag Thiazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives

Also Published As

Publication number Publication date
NO20011908L (no) 2001-04-18
JP2002528442A (ja) 2002-09-03
KR100469219B1 (ko) 2005-02-07
CO5150186A1 (es) 2002-04-29
HK1047281A1 (zh) 2003-02-14
NO20011908D0 (no) 2001-04-18
AU760219B2 (en) 2003-05-08
DK1123283T3 (da) 2004-09-13
PE20001116A1 (es) 2000-10-27
RU2214404C2 (ru) 2003-10-20
EP1123283A1 (fr) 2001-08-16
BR9914666A (pt) 2001-07-17
WO2000024724A1 (fr) 2000-05-04
KR20010080243A (ko) 2001-08-22
CZ20011395A3 (cs) 2001-08-15
CN1359381A (zh) 2002-07-17
DE69917058T2 (de) 2005-04-07
HRP20010275A2 (en) 2002-06-30
ATE266012T1 (de) 2004-05-15
ZA200102653B (en) 2002-07-01
JP3530137B2 (ja) 2004-05-24
AU1151900A (en) 2000-05-15
DE69917058D1 (de) 2004-06-09
YU29201A (sh) 2005-06-10
NZ510676A (en) 2003-06-30
AR023058A1 (es) 2002-09-04
PL347427A1 (en) 2002-04-08
ES2221482T3 (es) 2004-12-16
HUP0104202A3 (en) 2003-12-29
PT1123283E (pt) 2004-09-30
US6297266B1 (en) 2001-10-02
CA2347741A1 (fr) 2000-05-04
CA2347741C (fr) 2006-12-12
ID28356A (id) 2001-05-17
HUP0104202A2 (hu) 2002-03-28
CN1211375C (zh) 2005-07-20
EP1123283B1 (fr) 2004-05-06
IL142090A0 (en) 2002-03-10
TR200101115T2 (tr) 2002-01-21

Similar Documents

Publication Publication Date Title
PT930302E (pt) Derivados de benzo-sulfona
NO20010193L (no) Tiobenzimidazol-derivater
MA26766A1 (fr) Derives de phenylglycine
ATE426598T1 (de) Epothilonderivate
PT1104422E (pt) Derivados de fenilxantina
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
MA26591A1 (fr) Nouveaux derives de thiazole
PT1140924E (pt) Derivados de piperazina
PT1056716E (pt) Derivados de ciclo-hexanodiolo
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de) Chromanderivate
MA26756A1 (fr) Derives de thiazole
DK1060183T3 (da) 5-deoxycytidinderivater
MA26480A1 (fr) Derives de phenoxymethylpiperidine
DE69805392D1 (de) Thiazol-Derivate
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate